Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
3
|
| gptkbp:bfsParent |
gptkb:Regeneron_Pharmaceuticals
|
| gptkbp:acquired |
certain assets from Confluence Pharmaceuticals
|
| gptkbp:acquisition |
acquired by a larger pharmaceutical company in the past
|
| gptkbp:advocates_for |
supports patient advocacy initiatives
|
| gptkbp:business_model |
operates on a biotechnology business model
|
| gptkbp:can_lead_to |
gptkb:ATI-501
|
| gptkbp:ceo |
gptkb:Dr._Neal_Walker
|
| gptkbp:clinical_trial |
publishes clinical data in scientific journals
conducts clinical research studies clinical stage company conducts trials in various phases announces clinical trial results to the public conducts clinical trials for drug development manages clinical trial phases effectively |
| gptkbp:collaborations |
engages in collaborations with academic institutions
|
| gptkbp:committee |
has a scientific advisory board
|
| gptkbp:community_engagement |
engages with the community through outreach programs
|
| gptkbp:develops |
therapeutics for skin diseases
|
| gptkbp:employees |
employs a team of scientists and professionals
|
| gptkbp:focus |
maintains a patient-focused approach
|
| gptkbp:focuses_on |
dermatology
|
| gptkbp:founded |
gptkb:2012
|
| gptkbp:governed_by |
engages in business development activities
|
| gptkbp:headquarters |
gptkb:Wayne,_Pennsylvania
|
| gptkbp:healthcare |
engages with healthcare professionals for insights
pursues therapeutic innovation in dermatology. |
| https://www.w3.org/2000/01/rdf-schema#label |
Aclaris Therapeutics
|
| gptkbp:invention |
holds multiple patents for its technologies
|
| gptkbp:investment |
gptkb:Company
provides investor relations information focuses on the dermatology market receives investments from various sources |
| gptkbp:known_for |
Aclaris' proprietary technology platform
|
| gptkbp:language_of_instruction |
has a diverse pipeline of candidates
|
| gptkbp:leadership |
has a leadership team with extensive experience
|
| gptkbp:market |
conducts market research to inform strategies
plans product launches in the future |
| gptkbp:marketing_strategy |
develops a market strategy for its products
|
| gptkbp:mission |
to improve the lives of patients with skin diseases
|
| gptkbp:partnerships |
collaborates with other pharmaceutical companies
forms strategic partnerships with other firms |
| gptkbp:products |
Aclaris has products in development
develops product candidates for various indications |
| gptkbp:publishes |
produces scientific publications related to its research
|
| gptkbp:receives_funding_from |
has received venture capital funding
|
| gptkbp:regulatory_compliance |
prepares regulatory submissions for its products
seeks regulatory approval for its products |
| gptkbp:research_and_development |
invests in research and development activities
|
| gptkbp:research_areas |
autoimmune diseases
explores innovative therapeutic approaches |
| gptkbp:research_focus |
immune-mediated skin conditions
|
| gptkbp:traded_on |
gptkb:NASDAQ
|
| gptkbp:treatment |
aims to improve clinical outcomes for patients
targets specific therapeutic indications in dermatology |
| gptkbp:website |
www.aclaristx.com
|